Skip to main content

Table 3 Per protocol analysis of the primary endpoint

From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

 

Per protocol (PP) evaluation

Group I

Group II

Group III

Total

p-value

< D75

15

23

20

58

 

≥ D75

8

0

3

11

0.004*

Unknown

NA

NA

NA

NA

 

Total

23

23

23

69

 
  1. *Pearson Chi-Square Test (Exact-Sign).
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us